Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.24 +0.00 (+0.96%)
As of: Aug 21, 2026 · 11:33 AM EDT

Vistagen Therapeutics (VTGN) Notes Payables (2011 - 2025)

Vistagen Therapeutics (VTGN) posted Notes Payables of $400000.0 for Q4 2025, down 39.21% sequentially from $658000.0 in Q3 2025.

Vistagen Therapeutics (VTGN) Notes Payables (2011 - 2025) Analysis & Trends

Vistagen Therapeutics has reported Notes Payables for 12 years, with the latest figure at $400000.0 in Q4 2025.

  • Quarterly Notes Payables changed N/A year-over-year to $400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $400000.0 (changed N/A YoY) and the FY2023 annual result came in at $105000.0, changed N/A from the prior year.
  • Notes Payables fell to $400000.0 in Q4 2025 per VTGN's latest filing, from $658000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $1.0 million in Q2 2022 and troughed at $105000.0 in Q1 2023.
  • A 3-year average of $633387.5 and a median of $694000.0 in 2022 frame the typical range for Notes Payables.
  • The widest YoY moves for Notes Payables: up 24.44% in 2023, down 24.44% in 2023.
  • Over 3 years, Notes Payables stood at $419100.0 in 2022, then soared by 87.12% to $784200.0 in 2023, then tumbled by 48.99% to $400000.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods registered $400000.0, $658000.0, and $933000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.81 Bn 131.96 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.56 Bn 78.56 Bn 3.93 Bn
3 Argenx Se 65.72 Bn 60.53 Bn 1.37 Bn
4 Moderna 58.75 Bn 53.61 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.76 Bn 28.45 Bn 992.69 Mn
7 BioNTech SE 28.59 Bn 10.19 Bn 668.28 Mn
8 Insmed 27.63 Bn 26.47 Bn 358.27 Mn
9 Royalty Pharma 27.24 Bn 26.40 Bn -
10 Vistagen Therapeutics 10.42 Mn 10.42 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 400,000.00
Sep 30, 2025 658,000.00
Jun 30, 2025 933,000.00
Jun 30, 2023 784,200.00
Mar 31, 2023 105,000.00
Dec 31, 2022 419,100.00
Sep 30, 2022 730,000.00
Jun 30, 2022 1.04 Mn
Mar 31, 2020 56,500.00
Mar 31, 2019 57,300.00
Mar 31, 2018 53,900.00
Mar 31, 2017 54,800.00
Mar 31, 2016 43,600.00
Jun 30, 2014 1.96 Mn
Mar 31, 2014 396,000.00
Dec 31, 2013 2.48 Mn
Sep 30, 2013 2.35 Mn
Jun 30, 2013 6.95 Mn
Mar 31, 2013 1.80 Mn
Dec 31, 2012 1.91 Mn